logo
Select company
Select metric
$ 24.17MConsolidated Income
VS
Market
57
Sector
85
Industry
94
History
100
$ 10.05Close
$ 3.7 - $ 11.11 52-Week Range
Ticker Information

Ticker

GLUE

Company Name

MONTE ROSA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MONTE ROSA THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GLUE - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ 24.17M
3/31/2025$ 6.15M
12/31/2024$ -72.7M
9/30/2024$ -119.39M
6/30/2024$ -130.41M
3/31/2024$ -135.28M
12/31/2023$ -135.35M
9/30/2023$ -132.88M
6/30/2023$ -125.32M
3/31/2023$ -116.61M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MONTE ROSA THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -35.88M.
  • Over the past 5 years, MONTE ROSA THERAPEUTICS INC's average Cons. Inc. has been $ -89.78M.
  • The median Cons. Inc. for MONTE ROSA THERAPEUTICS INC during this period was $ -104.83M
  • MONTE ROSA THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ 24.17M.
  • The lowest Cons. Inc. recorded by MONTE ROSA THERAPEUTICS INC in the same timeframe $ -135.35M

MONTE ROSA THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
VNDA : VANDA PHARMACEUTICALS INC $ -66.94MHRTX : HERON THERAPEUTICS INC $ -931KARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ -60.16MCTMX : CYTOMX THERAPEUTICS INC $ 47.98MRGNX : REGENXBIO INC $ -175.57MMGNX : MACROGENICS INC $ -36.4MTRDA : ENTRADA THERAPEUTICS INC $ -73.35MPBYI : PUMA BIOTECHNOLOGY INC $ 48.45MCDXS : CODEXIS INC $ -64.98MSCPH : SCPHARMACEUTICALS INC $ -91.72M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

GLUE - Consolidated Income, Last 5 years

$ -135.35M

Minimum

Dec 31, 2023

$ 24.17M

Maximum

Jun 30, 2025

$ -89.78M

Average

$ -104.83M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M